Jiangsu Hengrui Medicine
600276.SS
#467
Rank
โ‚ฌ40.74 B
Marketcap
6,39ย โ‚ฌ
Share price
-1.00%
Change (1 day)
1.06%
Change (1 year)
Jiangsu Hengrui Medicine Company Limited is a Chinese pharmaceutical company engaged in the R&D, manufacturing and sales of healthcare products, including antineoplastic drugs, angiomyocardiac drugs, drugs for surgery, contrast agents and antibiotics

Jiangsu Hengrui Medicine (600276.SS) - Total debt

Total debt on the balance sheet as of September 2024 : โ‚ฌ11.57 Million

According to Jiangsu Hengrui Medicine 's latest financial reports the company's total debt is โ‚ฌ11.57 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

Jiangsu Hengrui Medicine - Total debt on balance sheet (from 2000 to 2024)

Total debt by year

Year Total debt Change
2022-12-31โ‚ฌ0.18 B775%
2021-12-31โ‚ฌ21 M
2015-12-31โ‚ฌ1.41 M6.59%
2014-12-31โ‚ฌ1.32 M-44.51%
2013-12-31โ‚ฌ2.39 M97.36%
2012-12-31โ‚ฌ1.21 M-50.52%
2011-12-31โ‚ฌ2.45 M7.76%
2010-12-31โ‚ฌ2.27 M122.53%
2009-12-31โ‚ฌ1.02 M
2007-12-31โ‚ฌ5.63 M20.89%
2006-12-31โ‚ฌ4.66 M-7.21%
2005-12-31โ‚ฌ5.02 M-43.11%
2004-12-31โ‚ฌ8.82 M-75.82%
2003-12-31โ‚ฌ36.51 M23.18%
2002-12-31โ‚ฌ29.64 M-13.98%
2001-12-31โ‚ฌ34.46 M47.09%
2000-12-31โ‚ฌ23.42 M-5.93%
1999-12-31โ‚ฌ24.9 M70.06%
1998-12-31โ‚ฌ14.64 M10.23%
1997-12-31โ‚ฌ13.28 M